Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedAug 15, 2018Prednisolone Sodium Phosphate Oral SolutionDefective Container: Tamper Evident foil seal not completely intact.Morton Grove Pharmaceuticals, Inc. · D-1042-2018Class IIITerminatedAug 15, 2018Diazepam Rectal GelLabeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.Valeant Pharmaceuticals North America LLC · D-1041-2018Class IITerminatedAug 15, 2018Kit for the Preparation of Technetium Tc99m MedronateLack of assurance of sterility: Technetium TC-99M Medronate Kit has a reported breach of sterility.Pharmalucence, Inc. · D-1040-2018Class IITerminatedAug 15, 2018Valsartan/HCTZ 320/25mg TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.NuCare Pharmaceuticals Inc · D-1039-2018Class IITerminatedAug 15, 2018Valsartan/HCTZ 160/25mg TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.NuCare Pharmaceuticals Inc · D-1038-2018Class IITerminatedAug 15, 2018Valsartan/HCTZ 160/12.5 mg TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.NuCare Pharmaceuticals Inc · D-1037-2018Class IIITerminatedAug 15, 2018Levofloxacin Injection in 5% DextroseSuperpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.Baxter Healthcare Corporation · D-1036-2018Class IIITerminatedAug 15, 2018Levofloxacin Injection in 5% DextroseSuperpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.Baxter Healthcare Corporation · D-1035-2018Class IIITerminatedAug 15, 2018Levofloxacin Injection in 5% DextroseSuperpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.Baxter Healthcare Corporation · D-1034-2018Class IIITerminatedAug 8, 2018Moxifloxacin Ophthalmic Solution USPFailed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.Lupin Pharmaceuticals Inc. · D-1050-2018Class IIITerminatedAug 8, 2018Fluconazole InjectionSuperpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.Renaissance Lakewood, LLC · D-1033-2018Class IIITerminatedAug 8, 2018Fluconazole InjectionFailed Stability Specifications: lot out of specification for elevated water vapor.Renaissance Lakewood, LLC · D-1032-2018Class IIITerminatedAug 8, 2018Fluconazole InjectionSuperpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.Renaissance Lakewood, LLC · D-1031-2018Class IITerminatedAug 8, 2018Valsartan 320 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Bryant Ranch Prepack Inc. · D-1029-2018Class IITerminatedAug 8, 2018Valsartan 320 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Bryant Ranch Prepack Inc. · D-1028-2018Class IITerminatedAug 8, 2018Valsartan 80 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Bryant Ranch Prepack Inc. · D-1027-2018Class IITerminatedAug 8, 2018Doxycycline Hyclate TabletsFailed Dissolution SpecificationsMajor Pharmaceuticals · D-1026-2018Class IITerminatedAug 8, 2018Doxycycline Hyclate TabletsFailed Dissolution Specifications:West-Ward Columbus Inc · D-1025-2018Class IITerminatedAug 8, 2018Doxycycline Hyclate TabletsFailed Dissolution Specifications:West-Ward Columbus Inc · D-1024-2018Class IITerminatedAug 8, 2018Daptomycin for InjectionMicrobial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.Pfizer · D-1023-2018Class IITerminatedAug 8, 2018Valsartan tablets 160 mgCarcinogen impurity detected in API used to manufacture drug product.H J Harkins Company Inc dba Pharma Pac · D-1022-2018Class IITerminatedAug 8, 2018Valsartan/HCTZ 320mg/12.5 mg tabletCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.RemedyRepack Inc. · D-1021-2018Class IITerminatedAug 8, 2018Valsartan/HCTZ 160 mg/12.5 mg tabletCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.RemedyRepack Inc. · D-1020-2018Class IITerminatedAug 8, 2018Indomethacin CapsulesFailed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.Hetero Labs, Ltd. - Unit III · D-1019-2018Class IITerminatedAug 8, 2018Potassium Citrate Extended-Release TabletsFailed Tablet/Capsule Specifications: Tablet breakageVensun Pharmaceuticals Inc · D-1018-2018Class IITerminatedAug 8, 2018Potassium Citrate Extended-Release TabletsFailed Tablet/Capsule Specifications: Tablet breakageVensun Pharmaceuticals Inc · D-1017-2018Class IIITerminatedAug 1, 2018Enalapril MaleateOut-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.Aidarex Pharmaceuticals LLC · D-0992-2018Class IIITerminatedAug 1, 2018Enalapril MaleateOut-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.Aidarex Pharmaceuticals LLC · D-0991-2018Class IIITerminatedAug 1, 2018Enalapril MaleateOut-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.Aidarex Pharmaceuticals LLC · D-0990-2018Class IIOngoingAug 1, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0989-2018Class IIOngoingAug 1, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0988-2018Class IIOngoingAug 1, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0987-2018Class IIOngoingAug 1, 2018Valsartan TabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0986-2018Class IIOngoingAug 1, 2018Valsartan and HydrochlorothiazideCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0985-2018Class IIOngoingAug 1, 2018Valsartan and HydrochlorothiazideCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0984-2018Class IIOngoingAug 1, 2018Valsartan and HydrochlorothiazideCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0983-2018Class IIOngoingAug 1, 2018Valsartan and HydrochlorothiazideCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0982-2018Class IIOngoingAug 1, 2018Valsartan and HydrochlorothiazideCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Teva Pharmaceuticals USA · D-0981-2018Class IIITerminatedAug 1, 2018Enalapril Maleate TabletsFailed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification...Major Pharmaceuticals · D-0980-2018Class IIITerminatedAug 1, 2018Enalapril Maleate TabletsFailed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification...Major Pharmaceuticals · D-0979-2018

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.